(5R,8S,11R,12S,15S,18S,19S,22R)-15-(1H-indol-3-ylmethyl)-18-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dienyl]-1,5,12,19-tetramethyl-2-methylidene-8-(2-methylpropyl)-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptazacyclopentacosane-11,22-dicarboxylic acid

MCLW; LC-ESI-QFT; MS2; CE: 120%; R=17500; [M+H]+

MCLW; LC-ESI-QFT; MS2; CE: 120%; R=17500; [M-H]-

MCLW; LC-ESI-QFT; MS2; CE: 15%; R=17500; [M+H]+

MCLW; LC-ESI-QFT; MS2; CE: 15%; R=17500; [M-H]-

MCLW; LC-ESI-QFT; MS2; CE: 150%; R=17500; [M+H]+

MCLW; LC-ESI-QFT; MS2; CE: 150%; R=17500; [M-H]-

MCLW; LC-ESI-QFT; MS2; CE: 180%; R=17500; [M+H]+

MCLW; LC-ESI-QFT; MS2; CE: 180%; R=17500; [M-H]-

MCLW; LC-ESI-QFT; MS2; CE: 30%; R=17500; [M+H]+

MCLW; LC-ESI-QFT; MS2; CE: 30%; R=17500; [M-H]-

MCLW; LC-ESI-QFT; MS2; CE: 45%; R=17500; [M+H]+

MCLW; LC-ESI-QFT; MS2; CE: 45%; R=17500; [M-H]-

MCLW; LC-ESI-QFT; MS2; CE: 60%; R=17500; [M+H]+

MCLW; LC-ESI-QFT; MS2; CE: 60%; R=17500; [M-H]-

MCLW; LC-ESI-QFT; MS2; CE: 75%; R=17500; [M+H]+

MCLW; LC-ESI-QFT; MS2; CE: 75%; R=17500; [M-H]-

MCLW; LC-ESI-QFT; MS2; CE: 90%; R=17500; [M+H]+

MCLW; LC-ESI-QFT; MS2; CE: 90%; R=17500; [M-H]-